Shengming Deng
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 21
- Pancreatic and Hepatic Oncology Research 9
- Peptidase Inhibition and Analysis 4
-
- Radiomics and Machine Learning in Medical Imaging 11
- Medical Imaging Techniques and Applications 8
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Guopei Luo (15 shared papers)Xianjun Yu (15 shared papers)Chen Liu (12 shared papers)Yitao Gong (11 shared papers)Yunzhen Qian (11 shared papers)Kaizhou Jin (10 shared papers)Qiuyi Huang (8 shared papers)Zhiyao Fan (9 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Technology in Cancer Research & Treatment (4 papers)Contrast Media & Molecular Imaging (4 papers)Medicine (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shengming Deng
79 papers receiving 2.0k citations
Shengming Deng's Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 703
- Cancer Research 260
- Radiology, Nuclear Medicine and Imaging 391
- Biomaterials 157
- Immunology 196
Countries citing papers authored by Shengming Deng
This map shows the geographic impact of Shengming Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengming Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengming Deng more than expected).
Fields of papers citing papers by Shengming Deng
This network shows the impact of papers produced by Shengming Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengming Deng. The network helps show where Shengming Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengming Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter Hit paper breakdown → | 2020 | 270 |
| 2 | 2020 | 241 | |
| 3 | 2011 | 241 | |
| 4 | 2018 | 188 | |
| 5 | 2014 | 97 | |
| 6 | 2015 | 64 | |
| 7 | 2020 | 58 | |
| 8 | 2020 | 57 | |
| 9 | 2018 | 53 | |
| 10 | 2019 | 51 | |
| 11 | 2021 | 41 | |
| 12 | 2019 | 32 | |
| 13 | 2013 | 32 | |
| 14 | 2015 | 31 | |
| 15 | 2019 | 29 | |
| 16 | 2013 | 27 | |
| 17 | 2023 | 24 | |
| 18 | 2022 | 24 | |
| 19 | 2018 | 23 | |
| 20 | 2021 | 22 |
About Shengming Deng
Shengming Deng is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Epidemiology and Pathology and Forensic Medicine, having authored 81 papers that have together received 2.0k indexed citations. Recurring topics across this work include Radiomics and Machine Learning in Medical Imaging (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), Medical Imaging Techniques and Applications (8 papers), Neuroendocrine Tumor Research Advances (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Oncology (703 citations), Cancer Research (260 citations), Radiology, Nuclear Medicine and Imaging (391 citations), Biomaterials (157 citations) and Immunology (196 citations). Shengming Deng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guopei Luo, Xianjun Yu, Chen Liu, Yitao Gong, Yunzhen Qian, Kaizhou Jin, Qiuyi Huang, Zhiyao Fan, Quanxing Ni and Cheng He. Their work appears in journals such as Frontiers in Oncology, Technology in Cancer Research & Treatment, Contrast Media & Molecular Imaging, Medicine and Acta Biochimica et Biophysica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.